Genentech

gene.com · South San Francisco, United States of America

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes biologic therapies, primarily for oncology, immunology, and neuroscience indications. It conducts research and clinical development in-house and generates revenue through the sale of prescription drugs and biologic treatments worldwide, largely via its parent company Roche’s commercial infrastructure. The company also partners with other biopharmaceutical firms and research institutions on drug discovery and development programs.

Revenue
$1B+
Employees
5,001+
Founded
1976
Headquarters
South San Francisco, United States of America

Genentech customers on Arbolus

Total customers 10 8 current · 2 former
Reviews growth 6 new reviews since Jun 2026

Customers who reviewed Genentech

Seniority of Genentech customers

Most people who reviewed Genentech hold C-Suite roles (62%), followed by Director (38%).

  • C-Suite 62%
  • Director 38%

Customers sample

Executive C-Suite NPS 8 Not renewing
Other Analyst Not specified NPS 9 Undecided
Operations Manager Director NPS 10

Employer names and spend open once the report publishes.

What 10 Arbolus experts think of Genentech

Overall sentiment: Neutral

NPS distribution shows a concentration of high scores (9-10) from User roles in public safety and non-healthcare settings, but lower to moderate scores from Influencers in core healthcare and research (ranging from 5 to 9). Renewal intent is strongly split: none of the high spenders are confident in renewal, with 100% uncertainty at the Pilot stage. Implementation stickiness is limited, with most customers in Pilot or uncertain stages, and only three in post-implementation. Major themes include positive front-line sentiment but cautious institutional commitment.

Tell us when the Genentech report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

30 Net Promoter Score, from 10 scored reviews
  • Promoters 5
  • Passives 3
  • Detractors 2

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 20%
  • Will renew 1
  • Undecided 3
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 0% 3 answers
  • Director 100% 1 answer
  • Not specified 0% 1 answer
  • 9/10 Average score from customers who will renew
  • 8/10 Average score from undecided customers
  • 8/10 Average score from customers not renewing

For people who use Genentech

Do you use Genentech at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 10 customers of Genentech have already contributed

Takes a few minutes. Your identity stays anonymous.